These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26163226)

  • 21. Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):71-3. PubMed ID: 3132384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.
    Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit AC; Schmitz FJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):938-42. PubMed ID: 11181385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial and anti-biofilm effects of fatty acids extract of dried
    Liu J; Jiang J; Zong J; Li B; Pan T; Diao Y; Zhang Z; Zhang X; Lu M; Wang S
    Nat Prod Res; 2021 May; 35(10):1702-1705. PubMed ID: 31180246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations.
    Lupatini NR; Danopoulos P; Swikidisa R; Alves PV
    Int J Pharm Compd; 2016; 20(4):333-337. PubMed ID: 28333678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes.
    Haq FU; Imran M; Saleem S; Aftab U; Ghazal A
    Arch Microbiol; 2022 Jun; 204(7):391. PubMed ID: 35699800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigella sativa seed extract applicability in preparations against methicillin-resistant Staphylococcus aureus and effects on human dermal fibroblasts viability.
    Gawron G; Krzyczkowski W; Lemke K; Ołdak A; Kadziński L; Banecki B
    J Ethnopharmacol; 2019 Nov; 244():112135. PubMed ID: 31377263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activity of ceftobiprole against Gram-positive cocci.
    Betriu C; Culebras E; Gómez M; López-Fabal F; Rodríguez-Avial I; Picazo JJ
    Int J Antimicrob Agents; 2010 Aug; 36(2):111-3. PubMed ID: 20554163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K; Ohno A; Takahashi S; Hayashi M; Yamanaka K; Hirakata Y; Mitsuyama J
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Watanabe A; Aoki N; Matsumoto T; Yoshida M; Sato J; Wakamura T; Sunakawa K; Kadota J; Kiyota H; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Fujiuchi S; Takahashi M; Takeuchi K; Takeda H; Ikeda H; Miki M; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Morino E; Takasaki J; Mezaki K; Chonabayashi N; Tanaka C; Sugiura H; Goto H; Saraya T; Kurai D; Katono Y; Inose R; Niki Y; Takuma T; Kudo M; Ehara S; Sato Y; Tsukada H; Watabe N; Honma Y; Mikamo H; Yamagishi Y; Nakamura A; Ohashi M; Seki M; Hamaguchi S; Toyokawa M; Fujikawa Y; Mitsuno N; Ukimura A; Miyara T; Nakamura T; Mikasa K; Kasahara K; Ui K; Fukuda S; Nakamura A; Morimura M; Yamashita M; Takesue Y; Wada Y; Sugimoto K; Kusano N; Nose M; Mihara E; Kuwabara M; Doi M; Watanabe Y; Tokuyasu H; Hino S; Negayama K; Mukae H; Kawanami T; Ota T; Fujita M; Honda J; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Kaku N; Fujita J; Higa F; Tateyama M
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
    Ma S; Jiao B; Ju Y; Zheng M; Ma R; Liu L; Zhang L; Shen X; Ma C; Meng Y; Wang H; Qi Y; Ma X; Cui W
    Eur J Med Chem; 2011 Feb; 46(2):556-66. PubMed ID: 21159410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Green Biosynthesis, Antioxidant, Antibacterial, and Anticancer Activities of Silver Nanoparticles of
    Nallappan D; Fauzi AN; Krishna BS; Kumar BP; Reddy AVK; Syed T; Reddy CS; Yaacob NS; Rao PV
    Biomed Res Int; 2021; 2021():5125681. PubMed ID: 34631882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and antibacterial activity of novel 4″-O-(1-aralkyl-1,2,3-triazol-4-methyl-carbamoyl) azithromycin analogs.
    Wang Y; Cong C; Chai WC; Dong R; Jia L; Song D; Zhou Z; Ma S
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3872-3877. PubMed ID: 28655423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
    Ma C; Liu Z; Song H; Jiang R; He F; Ma S
    J Antibiot (Tokyo); 2010 Jan; 63(1):3-8. PubMed ID: 19911029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Broth Macrodilution Volatilization Method for Antibacterial Susceptibility Testing of Volatile Agents and Evaluation of Their Toxicity Using Modified MTT Assay In Vitro.
    Houdkova M; Chaure A; Doskocil I; Havlik J; Kokoska L
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Activity of telithromycin and other oral antibiotics against respiratory tract pathogens with acquired mechanisms of resistance].
    Gómez-Garcés JL; Alós JI; Hernáiz C; Gómez C
    Enferm Infecc Microbiol Clin; 2004; 22(6):323-7. PubMed ID: 15228898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.
    Schmitz FJ; Boos M; Mayer S; Köhrer K; Scheuring S; Fluit AC
    Antimicrob Agents Chemother; 2002 Mar; 46(3):934-5. PubMed ID: 11850293
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus.
    Hesje CK; Drlica K; Blondeau JM
    J Antimicrob Chemother; 2015 Feb; 70(2):494-7. PubMed ID: 25324419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.